OpinionAntibodies Part 3: In whose corner is genome editing’s best cut-man sitting?Author:Aaron Viny, MDPublish date: April 5, 2017We are in the midst of a revolution in genome editing. Science now exists in “AC,” or after CRISPR. Able to speedily and efficiently make genomic c...Read More
OpinionFOUND IN TRANSLATION Minimal nomenclature and maximum sensitivity complicate MRD measuresAuthor:Aaron Viny, MDPublish date: December 22, 2016Real time quantitative polymerase chain reaction (RT-qPCR) and next generation sequencing (NGS) requires a leukemia-specific abnormality but has th...Read More
